KIR5.1 Antikörper (PE)
Kurzübersicht für KIR5.1 Antikörper (PE) (ABIN1430105)
Target
Alle KIR5.1 (KCNJ16) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- KIR5.1 Polyclonal Antibody, PE Conjugated
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Homologie
- Dog,Horse,Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human KIR5.1
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB(1:500-2000)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- KIR5.1 (KCNJ16) (Potassium Inwardly-Rectifying Channel, Subfamily J, Member 16 (KCNJ16))
-
Andere Bezeichnung
- Kir5.1
-
Hintergrund
- Synonyms: 6430410F18Rik, AI132396, BIR9, Inward rectifier K channel Kir5.1, Inward rectifier K(+) channel Kir5.1, Inward rectifier potassium channel 16, IRK16, IRKG, KCNJ16, MGC33717, Potassium channel inwardly rectifying subfamily J member 16, Potassium inwardly rectifying channel subfamily J member 16, RP23-218O16.1, IRK16_HUMAN.
-
Gen-ID
- 3773
-
UniProt
- Q9NPI9
Target
-